CY1119940T1 - Παραγοντας για χρηση στην περιπτωση δυσανεξιας στη φρουκτοζη - Google Patents
Παραγοντας για χρηση στην περιπτωση δυσανεξιας στη φρουκτοζηInfo
- Publication number
- CY1119940T1 CY1119940T1 CY20181100218T CY181100218T CY1119940T1 CY 1119940 T1 CY1119940 T1 CY 1119940T1 CY 20181100218 T CY20181100218 T CY 20181100218T CY 181100218 T CY181100218 T CY 181100218T CY 1119940 T1 CY1119940 T1 CY 1119940T1
- Authority
- CY
- Cyprus
- Prior art keywords
- fructose
- case
- agent
- fruitsosis
- tolerance
- Prior art date
Links
- 229930091371 Fructose Natural products 0.000 abstract 3
- 239000005715 Fructose Substances 0.000 abstract 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 206010072104 Fructose intolerance Diseases 0.000 abstract 2
- 206010019878 Hereditary fructose intolerance Diseases 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 108700040099 Xylose isomerases Proteins 0.000 abstract 1
- 102000016679 alpha-Glucosidases Human genes 0.000 abstract 1
- 108010028144 alpha-Glucosidases Proteins 0.000 abstract 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 235000011073 invertase Nutrition 0.000 abstract 1
- 239000001573 invertase Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/52—Isomerases (5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01124—Fructose 5-dehydrogenase (NADP+) (1.1.1.124)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/0102—Alpha-glucosidase (3.2.1.20)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01026—Beta-fructofuranosidase (3.2.1.26), i.e. invertase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01005—Xylose isomerase (5.3.1.5)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005055081 | 2005-11-16 | ||
| DE102005056169 | 2005-11-23 | ||
| DE102005060769 | 2005-12-16 | ||
| DE102005060768 | 2005-12-16 | ||
| DE102006000873 | 2006-01-04 | ||
| DE102006000881 | 2006-01-04 | ||
| DE102006001015 | 2006-01-05 | ||
| US75742406P | 2006-01-10 | 2006-01-10 | |
| US75741406P | 2006-01-10 | 2006-01-10 | |
| DE102006012244A DE102006012244A1 (de) | 2005-11-16 | 2006-03-15 | Mittel zur Anwendung bei Fructoseintoleranz |
| DE102006013624A DE102006013624B4 (de) | 2005-11-23 | 2006-03-22 | Mittel zur Anwendung bei Fructoseintoleranz |
| DE102006014423 | 2006-03-27 | ||
| US83105006P | 2006-07-17 | 2006-07-17 | |
| US83117406P | 2006-07-17 | 2006-07-17 | |
| PCT/IB2006/003223 WO2007057749A2 (en) | 2005-11-16 | 2006-11-15 | Agent for use in the case of fructose intolerance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119940T1 true CY1119940T1 (el) | 2018-12-12 |
Family
ID=38049014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181100218T CY1119940T1 (el) | 2005-11-16 | 2018-02-22 | Παραγοντας για χρηση στην περιπτωση δυσανεξιας στη φρουκτοζη |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20090081300A1 (https=) |
| EP (2) | EP1951290B1 (https=) |
| JP (1) | JP2009519897A (https=) |
| KR (1) | KR20080080122A (https=) |
| AU (1) | AU2006314188B2 (https=) |
| CA (1) | CA2669431C (https=) |
| CY (1) | CY1119940T1 (https=) |
| HR (1) | HRP20180327T1 (https=) |
| IL (1) | IL191363B (https=) |
| PL (1) | PL1951290T3 (https=) |
| SI (1) | SI1951290T1 (https=) |
| WO (1) | WO2007057749A2 (https=) |
| ZA (1) | ZA200805143B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1951289B1 (en) * | 2005-11-23 | 2018-11-14 | Pro Natura Gesellschaft für Gesunde Ernährung mbH | Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| AU2013211517B2 (en) * | 2005-11-23 | 2016-06-30 | Pro Natura Gesellschaft Fur Gesunde Ernahrung Mbh | Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| DE102007008664B4 (de) * | 2007-02-20 | 2021-07-29 | Vitacare Gmbh & Co. Kg | Mittel zur Anwendung bei Fructoseintoleranz |
| EP2161034A1 (de) | 2008-09-04 | 2010-03-10 | Sciotec Diagnostic Technologies GmbH | Behandlung von Fruktose-Malabsorption |
| EP2340035B1 (de) | 2008-09-04 | 2014-07-16 | Sciotec Diagnostic Technologies GmbH | Behandlung von fruktose-malabsorption |
| WO2010107414A1 (en) * | 2009-03-19 | 2010-09-23 | Amano Enzyme Inc. | Enzyme compositions and use thereof |
| EP3415631A1 (en) * | 2017-06-13 | 2018-12-19 | RWTH Aachen | Methods of producing 5-ketofructose |
| JP7469332B2 (ja) * | 2019-05-13 | 2024-04-16 | サミ－サビンサ グループ リミテッド | フルクトフィリック乳酸産生細菌 |
| CN112536005B (zh) * | 2020-11-05 | 2022-05-03 | 华南理工大学 | 一种淀粉包埋香气物质微胶囊及其制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107291A (en) * | 1969-06-05 | 1978-08-15 | Sankyo Company Limited | Compositions for cleaning teeth and oral cavity |
| US4396602A (en) * | 1981-09-22 | 1983-08-02 | Asahi Kasei Kogyo Kabushiki Kaisha | Blood glucose level lowering agents |
| DK8502857A (https=) * | 1984-06-25 | 1985-12-26 | ||
| JPS6236191A (ja) * | 1985-08-09 | 1987-02-17 | House Food Ind Co Ltd | 固定化酵素の製造方法 |
| SE8505783D0 (sv) | 1985-12-06 | 1985-12-06 | Rolf Bergkvist | Forfarande for framstellning av livsmedelsprodukter och dessas anvendning |
| JPH0640824B2 (ja) * | 1987-03-19 | 1994-06-01 | 東洋紡績株式会社 | 安定なフラクト−スデヒドロゲナ−ゼ組成物 |
| US5068110A (en) * | 1987-09-29 | 1991-11-26 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
| US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
| FI905402A7 (fi) | 1990-11-01 | 1992-05-02 | Alko Ab Oy | Oligosakkaridiseos ja menetelmä sen jälkikäsittelyksi |
| US5650156A (en) * | 1993-02-22 | 1997-07-22 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of nutriceuticals and compositions useful therefor |
| US5759539A (en) * | 1995-06-06 | 1998-06-02 | Georgia Research Foundation, Inc. | Method for rapid enzymatic alcohol removal |
| US6057139A (en) * | 1995-06-29 | 2000-05-02 | Mcneil-Ppc, Inc. | Preblend of microcrystalline cellulose and lactase for making tablets |
| CA2294525A1 (en) * | 1997-06-17 | 1998-12-23 | Monsanto Company | Expression of fructose 1,6 bisphosphate aldolase in transgenic plants |
| AU740108B2 (en) | 1997-06-17 | 2001-11-01 | Novozymes A/S | An oral care composition comprising a bacillus pullulanase and a dextranase |
| AU762967B2 (en) * | 1998-05-13 | 2003-07-10 | Novozymes A/S | Methods for using dehydrogenases in baking |
| CA2328137A1 (en) * | 1998-05-29 | 1999-12-09 | Novo Nordisk A/S | Methods for using xyloglucan endotransglycosylase in baking |
| US6042823A (en) | 1998-07-02 | 2000-03-28 | Amano Pharmaceuticals Co., Ltd. | Enzyme composition and use thereof |
| US7767203B2 (en) * | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| JP2000125883A (ja) * | 1998-10-21 | 2000-05-09 | Internatl Reagents Corp | フルクトキナーゼ及びその遺伝子 |
| AU6326699A (en) | 1998-11-05 | 2000-05-29 | Novozymes A/S | Methods for using a glucose isomerase in baking |
| IL138990A0 (en) * | 1999-02-12 | 2001-11-25 | Biostream Inc | Matrices for drug delivery and methods for making and using the same |
| EP1203822A1 (en) * | 2000-11-02 | 2002-05-08 | Societe Des Produits Nestle S.A. | Extracellular polysaccharide from Gluconacetobacter spp |
| US6754884B1 (en) | 2001-07-02 | 2004-06-22 | Bea Systems, Inc. | Programming language extensions for processing XML objects and related applications |
| JP4824886B2 (ja) * | 2001-09-11 | 2011-11-30 | 長岡香料株式会社 | フルクトース吸収阻害剤、組成物、および食品 |
| US20030113310A1 (en) * | 2001-12-17 | 2003-06-19 | Van Laere Katrien Maria Jozefa | Method for the treatment of obesity, overweight and fluctuations in blood insuline and/or glucose levels |
| ES2533469T3 (es) * | 2002-10-11 | 2015-04-10 | Novozymes A/S | Método de preparación de un producto tratado con calor |
| JP2004261174A (ja) * | 2003-02-13 | 2004-09-24 | Fujicco Co Ltd | 豆乳発酵物およびそれを用いた飲食品 |
| WO2004079848A2 (en) | 2003-03-03 | 2004-09-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Novel electrode with switchable and tunable power output and fuel cell using such electrode |
| JPWO2006004106A1 (ja) * | 2004-07-05 | 2008-04-24 | マルキンバイオ株式会社 | ザクロ果汁、ザクロ果汁粉末及び該粉末の製造方法 |
| EP1951289B1 (en) * | 2005-11-23 | 2018-11-14 | Pro Natura Gesellschaft für Gesunde Ernährung mbH | Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
-
2006
- 2006-11-15 PL PL06820896T patent/PL1951290T3/pl unknown
- 2006-11-15 JP JP2008540716A patent/JP2009519897A/ja active Pending
- 2006-11-15 EP EP06820896.6A patent/EP1951290B1/en active Active
- 2006-11-15 KR KR1020087014569A patent/KR20080080122A/ko not_active Withdrawn
- 2006-11-15 AU AU2006314188A patent/AU2006314188B2/en not_active Ceased
- 2006-11-15 HR HRP20180327TT patent/HRP20180327T1/hr unknown
- 2006-11-15 SI SI200632244T patent/SI1951290T1/en unknown
- 2006-11-15 WO PCT/IB2006/003223 patent/WO2007057749A2/en not_active Ceased
- 2006-11-15 EP EP17195181.7A patent/EP3318271A1/en not_active Withdrawn
- 2006-11-15 CA CA2669431A patent/CA2669431C/en not_active Expired - Fee Related
- 2006-11-15 US US12/093,822 patent/US20090081300A1/en not_active Abandoned
-
2008
- 2008-05-12 IL IL191363A patent/IL191363B/en active IP Right Grant
- 2008-06-12 ZA ZA2008/05143A patent/ZA200805143B/en unknown
-
2012
- 2012-11-12 US US13/674,841 patent/US9446101B2/en not_active Expired - Fee Related
-
2016
- 2016-09-19 US US15/269,943 patent/US10568942B2/en active Active
-
2018
- 2018-02-22 CY CY20181100218T patent/CY1119940T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20180327T1 (hr) | 2018-04-06 |
| WO2007057749A3 (en) | 2008-10-16 |
| US20090081300A1 (en) | 2009-03-26 |
| ZA200805143B (en) | 2012-02-29 |
| AU2006314188A1 (en) | 2007-05-24 |
| KR20080080122A (ko) | 2008-09-02 |
| SI1951290T1 (en) | 2018-04-30 |
| IL191363B (en) | 2018-05-31 |
| EP3318271A1 (en) | 2018-05-09 |
| US20180344818A1 (en) | 2018-12-06 |
| CA2669431C (en) | 2019-04-23 |
| EP1951290B1 (en) | 2017-12-27 |
| JP2009519897A (ja) | 2009-05-21 |
| PL1951290T3 (pl) | 2018-05-30 |
| WO2007057749A2 (en) | 2007-05-24 |
| CA2669431A1 (en) | 2007-05-24 |
| US10568942B2 (en) | 2020-02-25 |
| EP1951290A2 (en) | 2008-08-06 |
| US9446101B2 (en) | 2016-09-20 |
| AU2006314188B2 (en) | 2014-01-16 |
| US20130224171A1 (en) | 2013-08-29 |
| EP1951290A4 (en) | 2009-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119940T1 (el) | Παραγοντας για χρηση στην περιπτωση δυσανεξιας στη φρουκτοζη | |
| CY1117312T1 (el) | Θεραπευτικη αγωγη συνουκλεϊνοπαθειων | |
| CY1118984T1 (el) | Παρασκευη ενεργων, ακρως φωσφορυλιωμενων, ανθρωπινων λυσοσωμικων ενζυμων σουλφατασης και χρησεις αυτων | |
| CY1118934T1 (el) | Παρασκευη ενεργης ακρως φωσφορυλιωμενης ανθρωπινης ν-ακετυλογαλακτοζαμινης-6-σουλφατασης και χρησεις αυτης | |
| WO2011049958A3 (en) | Modulation of gel temperature of poloxamer-containing formulations | |
| CY1118714T1 (el) | Υψηλης συγγενειας ανθρωπινα αντισωματα κατα του ανθρωπινου ενεργοποιουμενου απο πρωτεαση υποδοχεα-2 | |
| BRPI0516830A (pt) | composições de droga de liberação sustentada convenientemente implantáveis | |
| CL2012003026A1 (es) | Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad. | |
| GT200500205A (es) | Nuevos anticuerpos anti-igf-ir y sus usos | |
| CY1116344T1 (el) | Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας | |
| AR057458A1 (es) | Polieteresteres reabsorbibles y su utilizacion para la preparacion de implantes medicinales | |
| BR112012029395A2 (pt) | lactamas piperdinil-substituídas como moduladores de gpr119 | |
| CY1120085T1 (el) | Παραγοντας προς χρηση στην περιπτωση δυσανεξιας στην φρουκτοζη | |
| UY31305A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen. | |
| SI1909843T1 (sl) | Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju | |
| CY1119850T1 (el) | Χρηση της μετφορμινης σε συνδυασμο με ενεργοποιητη γλυκοκινασης και συνθεσεων που περιλαμβανουν μετφορμινη και ενεργοποιητη γλυκοκινασης | |
| CY1117174T1 (el) | ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ | |
| CY1115961T1 (el) | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) | |
| WO2008094710A3 (en) | Diatom device | |
| CY1114125T1 (el) | Αδιπονεκτινη στην αγωγη εναντι πνευμονοπαθειας | |
| DK1719503T3 (da) | Anvendelse af stivelse med fraspaltede sidekæder i ekstrudering/sfæronisering af farmaceutiske pellets | |
| NO20082848L (no) | Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre | |
| BRPI0700133A (pt) | composição farmacêutica compreendendo tramadol e cetoprofeno em combinação | |
| JP2009292763A5 (https=) | ||
| WO2011127482A3 (en) | Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related thereto |